We are live on ! Find out more
IDXX icon

Idexx Laboratories

306 hedge funds and large institutions have $6.46B invested in Idexx Laboratories in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 134 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more call options, than puts

Call options by funds: $3.69M | Put options by funds: $1.52M

2.51% less ownership

Funds ownership: 98.69% → 96.18% (-2.5%)

3% less funds holding

Funds holding: 314 → 306 (-8)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

35% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 34

47% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 134

56% less capital inflows, than outflows

Capital inflows: $230M | Capital outflows: $527M

Holders
306
Holders Change
-8
Holders Change %
-2.55%
% of All Funds
8.77%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.23%
New
22
Increased
71
Reduced
134
Closed
34
Calls
$3.69​M
Puts
$1.52​M
Net Calls
+$2.16​M
Net Calls Change
-⁠$544​K

IDXX Hedge Fund Activity: Q2 2014 in Review

306 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2014, worth a combined $6.46B — up 5% from $6.15B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of IDXX and 22 opened new positions — a net loss of 12 holders — while 134 trimmed existing stakes and 71 added.

The largest buyer was First Trust Advisors, adding an estimated $27M. The largest seller was William Blair & Company, cutting an estimated $86.4M.

  • 306 institutional investors held Idexx Laboratories (IDXX) as of Q2 2014, down from 314 in Q1 2014.
  • Funds reported $6.46B of Idexx Laboratories stock for Q2 2014, up 5% quarter-over-quarter.
  • 22 funds opened new Idexx Laboratories positions in Q2 2014 and 34 closed out, a net change of -12 holders.
  • The largest Idexx Laboratories buyer in Q2 2014 was First Trust Advisors, an estimated $27M added.
  • The largest Idexx Laboratories seller in Q2 2014 was William Blair & Company, an estimated $86.4M sold.

Based on aggregated 13F filings for Q2 2014.